Search - tctmd.com

Displaying 21 - 40 of 48

Sort: Relevancy | Date

Presentation TCT 2017

Case Presentation #1: A Complex Left Main PCI Made Simple

Presenter: Amal Kumar Banerjee, Rabin dra Nath Chakraborty, Afzalur Rahman

October 29, 2017

Presentation TCT 2017

Tricuspid Valve Interventions: Patient Selection, Devices, and Predictions

Presenter: Antonio Colombo, Samir R. Kapadia, Azeem Latib

October 29, 2017

Presentation TCT 2017

CTO Intervention

Presenter: Ayman Abou El Magd, Mohamed Ahmed Sobhy, Sherif ELbeltagui

October 29, 2017

Presentation TCT 2017

IVUS-Guided vs OCT-Guided PCI: Advantages and Disadvantages

Presenter: Gary S. Mintz, Seung-Jung Park

October 29, 2017

Presentation TCT 2017

Next Generation BRS Platforms

Presenter: Gary S. Mintz, Seung-Jung Park, Alan C. Yeung

October 29, 2017

Presentation TCT 2017

Case Presentation 4: Carotid Artery Stenting

Presenter: Sergey A. Abugov, Juan F. Granada, Narek Zakaryan

October 29, 2017

Presentation TCT 2017

Complex and High-Risk PCI: Who Should Perform These Procedures?

Presenter: Anibal A. Damonte, Alejandro O. Palacios, Qi Zhang

October 29, 2017

Presentation TCT 2017

Heavy Coronary Calcification

Presenter: Ayman Abou El Magd, Mohamed Ahmed Sobhy, Amr Mahmoud Zaki

October 29, 2017

Presentation TCT 2017

BRS Randomized Trials: What Was Wrong the Lesions, the Scaffold, or the Technique?

Presenter: Gary S. Mintz, Seung-Jung Park

October 29, 2017

Presentation TCT 2017

Lessons from the ABSORB Clinical Program for the Future

Presenter: Gary S. Mintz, Seung-Jung Park, Patrick W. Serruys

October 29, 2017

Presentation TCT 2017

Mitral Valve Interventions: MitraClip, Annular Treatments, and Valves Where Will We Be in 5 Years? In 10 Years?

Presenter: Antonio Colombo, Azeem Latib, Jason H. Rogers

October 29, 2017

Presentation TCT 2017

UPLMPCI How to Use Evidence and Precision Medicine to Optimize Outcomes, a Case Example

Presenter: Ayman Abou El Magd, Mohamed Ahmed Sobhy, Hany Ragy

October 29, 2017

Presentation TCT 2017

Forty Years After the First PCI, Where Are We and Where Are We Headed?

Presenter: Alejandro Cherro, Alfredo E. Rodriguez, Spencer B. King III

October 29, 2017

News Opinion Fellow Talk

My Picks for Fellows Attending TCT 2017

Amit K. Gupta, MBBS, MD

October 26, 2017

News Conference News TCT 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Shelley Wood

October 20, 2017

News Daily News

What Works, What Matters? Patient-Centered Endpoints Gain Traction in CV Clinical Trials

Caitlin E. Cox

October 13, 2017

News Daily News

Rivaroxaban Trial in Patients With Embolic Stroke of Undetermined Source Stopped Early

Todd Neale

October 09, 2017

News Conference News ESC 2017

European Societies Issue New Valvular Heart Disease Guidelines, With Important Shifts

Shelley Wood

August 27, 2017

News Conference News SCCT 2017

Faster, On-site FFRCT May Be on the Horizon Through Innovation and Collaboration

Yael L. Maxwell

July 09, 2017

News Conference News TVT 2017

Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base

Michael O'Riordan

June 17, 2017

Advertisement

Case Presentation #1: A Complex Left Main PCI Made Simple

Tricuspid Valve Interventions: Patient Selection, Devices, and Predictions

CTO Intervention

IVUS-Guided vs OCT-Guided PCI: Advantages and Disadvantages

Next Generation BRS Platforms

Case Presentation 4: Carotid Artery Stenting

Complex and High-Risk PCI: Who Should Perform These Procedures?

Heavy Coronary Calcification

BRS Randomized Trials: What Was Wrong the Lesions, the Scaffold, or the Technique?

Lessons from the ABSORB Clinical Program for the Future

Mitral Valve Interventions: MitraClip, Annular Treatments, and Valves Where Will We Be in 5 Years? In 10 Years?

UPLMPCI How to Use Evidence and Precision Medicine to Optimize Outcomes, a Case Example

Forty Years After the First PCI, Where Are We and Where Are We Headed?

My Picks for Fellows Attending TCT 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

What Works, What Matters? Patient-Centered Endpoints Gain Traction in CV Clinical Trials

Rivaroxaban Trial in Patients With Embolic Stroke of Undetermined Source Stopped Early

European Societies Issue New Valvular Heart Disease Guidelines, With Important Shifts

Faster, On-site FFRCT May Be on the Horizon Through Innovation and Collaboration

Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content